MommaConnect, a mobile health platform (mHealth) based on our evidence-based Mother-Baby Connections (MBC) perinatal mental health program

项目摘要 背景：产后抑郁症(PPD)是最常见的分娩并发症，影响10%-15%的人 对母亲及其婴儿有长期不利健康后果的妇女。非裔美国人/黑人(AA/B)女性 患产后抑郁症的可能性是白人女性的两倍。然而，尽管后果严重，许多AA/B 由于心理健康污名等障碍，母婴二人组得不到专门的心理健康护理， 医疗保健不平等、儿童保育问题、交通问题以及难以获得量身定制的专门治疗 给PPD。此外，AA/B级女性对心理健康服务的使用也受到坚强的黑人女性的影响 图式(SBW；即AA/B级妇女认为需要“独立、自我沉默和自我牺牲”)。一个 需要基于证据的、与文化相关的心理健康计划来支持AA/B女性的需求。 从科学、技术和临床角度来看，MommaConnect在解决特定障碍方面具有新颖性 产后抑郁妇女的可及性、可接受性和可负担性，包括AA/B级母亲。特定于第一阶段 目标是： 1.与6-8名经历过的AA/B女性共同创建MommaConnect mHealth平台内容 PPD。我们将利用与AA/B女性组成的焦点小组共同创建MommaConnect平台。 2.对30名经历过PPD的AA/B女性进行MommaConnect平台可行性评估 与6名临床医生共12周。 方法：我们的SBIR第一阶段将通过快速支持共同创建和评估 移动健康应用程序MommaConnect提供为期12周的干预以减少产后抑郁的可行性 严重和提高母婴互动的质量，即支持健康婴儿的关键机制 发展。MommaConnect整合了两种公认的循证疗法：母婴互动 治疗(MBI)和人际心理治疗(IPT)。IPT和MBI共享一个人际框架， 强调母亲和婴儿之间的关键人际关系。 影响：这项研究的结果可以为进一步开发创新的交付模式提供参考 为产后抑郁妇女及其婴儿提供围产期心理健康治疗，改善获得心理健康服务的机会， 减少产后抑郁症状，促进积极的婴儿发育结果。

Project Summary Background: Postpartum depression (PPD) is the most common childbirth complication that affects 10-15% of all women, with long-term adverse health outcomes for mothers and their infants. African American/Black (AA/B) women are twice as likely to experience PPD compared to White women. However, despite severe outcomes, many AA/B mother-infant dyads do not receive specialized mental health care due to barriers such as mental health stigma, healthcare inequities, childcare issues, transportation challenges, and poor access to specialized treatment tailored to PPD. Furthermore, AA/B women’s use of mental health services is also influenced by the Strong Black Woman schema (SBW; i.e., AA/B women’s belief in the need to be “independent, self-silencing, and self-sacrificing”). An evidence-based, culturally-relevant mental health program is needed to support the needs of AA/B women. MommaConnect is novel from scientific, technical, and clinical perspectives in addressing specific barriers to accessibility, acceptability, and affordability among women with PPD, including AA/B mothers. Phase I specific aims are to: 1. Co-create the MommaConnect mHealth platform content with 6-8 AA/B women who have experienced PPD. We will leverage focus groups with AA/B women to co-create the MommaConnect platform. 2. Evaluate feasibility of the MommaConnect platform with 30 AA/B women who have experienced PPD for 12 weeks with 6 clinicians. Methods: Our SBIR Phase I will address these barriers by quickly supporting the co-creation and evaluation of the feasibility of MommaConnect, a mobile health application, which delivers a 12-week intervention to reduce PPD severity and improve the quality of mother-infant interaction, i.e., the critical mechanism that supports healthy infant development. MommaConnect integrates two established evidence-based therapies: Mother-Baby Interaction Therapy (MBI) and Interpersonal Psychotherapy (IPT). IPT and MBI share an interpersonal framework that emphasizes the critical interpersonal relationship between mothers and their infants. Implications: The outcomes from this study can inform further development of an innovative model of delivery of perinatal mental health treatment for women with PPD and their infants, improve access to mental health services, reduce PPD symptoms, and promote positive infant developmental outcomes.